-
Entity
-
Individual
-
Location
-
C/O Crispr Therapeutics, Inc., 610 Main Street, Cambridge, MA
-
Summary
-
The estimated net worth of James R. Kasinger is at least $3.37M dollars as of March 24, 2025. James R. Kasinger is the General Counsel and Secretary of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $3.37M.